Navigation Links
Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
Date:2/26/2008

PRINCETON, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced the completion of recruitment in the company's multi-center Phase 2a clinical study of PS433540 (DARA), the company's lead internal product candidate. The objective of the Phase 2a randomized, double-blind, placebo-controlled, parallel-group study is to evaluate the efficacy and safety of 200 and 500 mg of PS433540 in subjects with Stage I and Stage II hypertension.

"We have made good progress advancing DARA's clinical development. Not only did we initiate this Phase 2a study approximately six months ahead of our original clinical development timeline, but we have now completed enrollment in the study with the expectation of reporting results in the second quarter of 2008," said Les Browne, Ph.D., Pharmacopeia's President and Chief Executive Officer. "As this is the first PS433540 study to include hypertensive patients, we are pleased to have the opportunity to demonstrate that DARA can effectively lower blood pressure in this patient population."

Results from Phase 1 studies of PS433540 in normal subjects have indicated that the compound was well tolerated at all doses up to and including 1,000 mg a day for 14 days. Several studies including the multiple ascending dose (MAD) and angiotensin II challenge studies have shown that PS433540 appears to have a pharmacokinetic profile consistent with once-daily oral administration. In the angiotensin challenge study, 250 and 500 mg of PS433540 fully blocked the increase in blood pressure induced by administration of angiotensin II (AII) to healthy volunteers at least as well as 300 mg of irbesartan, the t
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
3. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
4. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
5. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
6. Pharmacopeia Announces Third Quarter 2007 Financial Results
7. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
8. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
9. Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
(Date:7/31/2014)... For the first time, cardiac surgeons, medical ... the SynCardia temporary Total Artificial Heart in a peer ... the Journal of Visualized Experiments website. ... the SynCardia Total Artificial Heart implantation   goo.gl/2OZyKW ... the SynCardia Total Artificial Heart," a July 18, 2014 ...
(Date:7/31/2014)... , July 31, 2014 The Galien Foundation ... Prix Galien USA Awards. The ... accolade and recognizes the technical, scientific and clinical research ... This year brings the highest number of nominees ... USA . Nominees include biomedical products across three ...
Breaking Medicine Technology:Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5
... Verisk Health announced that it ... include greater predictive power and reporting capabilities. The product is ... of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) system. ... department (ED) utilization and measure practice variation for both commercial ...
... Oct. 17, 2011 The Radiosurgery Society™ (RSS), a ... science and clinical practice of stereotactic body radiotherapy (SBRT) ... February 23-25 at the La Costa Resort in Carlsbad, ... the newly-named Radiosurgery Society has been expanded to serve ...
Cached Medicine Technology:Verisk Health's DxCG Risk Solutions Technology Ready to Support Industry Adoption of ICD-10-CM 2Announcing The Radiosurgery Society™ And Its 2012 SRS/SBRT Scientific Meeting 2Announcing The Radiosurgery Society™ And Its 2012 SRS/SBRT Scientific Meeting 3
(Date:7/31/2014)... (PRWEB) July 31, 2014 The VitaSleep ... open the airway and provide an easier breathing capacity ... end results are that people can breathe easier and ... is entirely adjustable so that it can meet the ... for snorers is often shared by actual customer reviews. ...
(Date:7/31/2014)... Colo. (PRWEB) July 31, 2014 A ... camp” is coming to the University of Colorado ... one-week destination weight loss boot camp and transformation program. ... collaboration between AHWC and Eyeworks USA, is an evidenced-based ... produced for ABC by Eyeworks USA. This season, the ...
(Date:7/31/2014)... July 31, 2014 Zensah®, a leading ... innovative compression elbow sleeve , designed to help ... in two new bright colors for summer. The compression ... blue. Made of innovative proprietary Zensah® fabric, the ... odor-preventing fabric. It features a no-slip cuff to ensure ...
(Date:7/31/2014)... NJ (PRWEB) July 31, 2014 ... leading gastroenterologist, Dr. Masood Rizvi, has joined our ... Dr. Rizvi to the community. Hundreds of highly ... Group, a comprehensive network of top doctors and ... of specialties. This latest acquisition represents CarePoint Health’s ...
(Date:7/31/2014)... 2014 Two years in the making, ... overview of the research behind the latest scientific findings ... and Vesanto Melina, well-respected authorities on plant-based nutrition, put ... safe and adequate for people at all stages of ... athletes and pregnant or lactating women. , Well-planned ...
Breaking Medicine News(10 mins):Health News:New Dental Device Reviews to Stop Snoring by VitalSleep 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 3Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 2Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 3Health News:Dr. Rizvi Joins CarePoint Health Medical Group 2Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 2Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 3
... professor in the department of mathematical sciences in ... received the honor of "Excellence in Upper Division ... at NJIT traditionally honors select faculty and staff ... excellence over a sustained period. ...
... News) -- The number of Americans who say they suffer ... decade, a new study shows. Researchers from the Johns ... self-reported mental health disability rose from 2 percent between 1997 ... increase amounts to nearly 2 million disabled adults, the study ...
... battered women,s shelters in the United States are children ... new, innovative online training program aims to elevate children,s ... and respond to the children and families they serve. ... , was created by the Minnesota Center Against Violence ...
... Researchers from the School of Science at Indiana ... of the brain,s neural circuitry that may provide ... is not transmitted correctly in the brains of ... scientists and clinicians correct these misfires. Work ...
... for diabetes complications, such as heart attack and stroke, ... levels. Reducing risk means reducing these values to ideal ... (BWH), achieving ideal levels may be as simple as ... are associated with faster achievement of blood glucose, blood ...
... Sweden have demonstrated for the first time that it is ... the common Cytomegalovirus (CMV). The virus, which is found in ... towards controlling tumour growth and reducing the size of the ... CMV is a common virus that is found in 70-75 ...
Cached Medicine News:Health News:Gifted mathematician honored at NJIT convocation 2Health News:Mental Health Disabilities in U.S. on the Rise: Study 2Health News:New online learning module gives children of domestic violence a voice 2Health News:New modeling of brain's circuitry may bring better understanding of Parkinson's disease 2Health News:Frequent doctor visits benefits patients with diabetes 2Health News:Treatment of common virus can reduce tumour growth 2
...
Anodized aluminum. Durable and lightweight with built-in protection against rust. Security locks ensure against accidental opening. Silicone matting/V-strips and bumper guards hold instruments in pla...
Diamond knife tray with silicone inserts to securely hold the diamond knife....
Size: 6 x 10 inches. Depth: 7 inches. Sterilizable plastic tray with silicone matting for supporting and protecting instruments....
Medicine Products: